Metlife (MET) Current Deferred Revenue (2020 - 2026)

Metlife has reported Current Deferred Revenue for 7 years, with the latest figure at $5.3 billion in Q2 2026.

• On a quarterly basis, Current Deferred Revenue rose 6.85% year-over-year to $5.3 billion in Q2 2026; TTM through Jun 2026 was $5.3 billion, a 6.85% increase from a year earlier, with the FY2025 full-year figure at $5.2 billion, up 11.37% from the prior year.
• Current Deferred Revenue was $5.3 billion for Q2 2026 at Metlife, up from $5.2 billion in the prior quarter.
• The five-year high for Current Deferred Revenue was $5.3 billion in Q2 2026, with the low at $3.8 billion in Q1 2022.
• Average Current Deferred Revenue over 5 years is $4.6 billion, with a median of $4.6 billion recorded in 2024.
• The sharpest annual moves came in 2023 and 2024: Current Deferred Revenue rose 17.22% in 2023, then increased 2.16% in 2024.
• Over 5 years, Current Deferred Revenue stood at $4.1 billion in 2022, then gained by 10.5% to $4.5 billion in 2023, then grew by 2.16% to $4.6 billion in 2024, then increased by 11.37% to $5.2 billion in 2025, then advanced by 2.42% to $5.3 billion in 2026.
• The last three Current Deferred Revenue figures came in at $5.3 billion (Q2 2026), $5.2 billion (Q1 2026), and $5.2 billion (Q4 2025), per Business Quant data.